Association of obesity with hypertension and dyslipidemia in type 2 diabetes mellitus subjects

Diabetes Metab Syndr. 2017 Jan-Mar;11(1):37-41. doi: 10.1016/j.dsx.2016.07.004. Epub 2016 Jul 21.

Abstract

Aim: Obesity and diabetes are contributed to cardiovascular disease risk. The current study was performed to evaluate the association of central and general obesity and cardio-metabolic risk factors, including dyslipidemia and hypertension in T2DM patients.

Methods: This was a cross-sectional study in T2DM adults. Body mass index (BMI) was used to identify general obesity and waist circumference (WC) was measured to define abdominal obesity (based on ATP III). Biochemical analyses, and anthropometric and blood pressure measurements were done for all participants.

Results: Participants with central obesity showed significantly higher systolic (132.5mmHg vs. 125.4mmHg, p=0.024) and diastolic blood pressures (84.9mmHg vs. 80mmHg, p=0.007) than participants without obesity. Dyslipidemia was more prevalent in all participants either by BMI (98.3% vs. 97%, 95% CI: 0.18-17.53) or by WC (97.2% vs. 98%, 95% CI: 0.07-7.19). Abdominal adiposity in diabetic subjects showed significant reverse association with high level of physical activity (OR=0.22, 95% CI: 0.06-0.85). Hypertriglyceridemia rate was increased with both central (OR=2.11; p=0.040) and general obesity (OR=2.68; p=0.021). After adjustment for energy intake and age, females had higher risk of general (OR=4.57, 95% CI=1.88-11.11) and central obesity (OR=7.93, 95% CI=3.48-18.08).

Conclusions: Females were more susceptible to obesity. Hypertension was associated with both obesity measures. Dyslipidemia, except for hypertriglyceridemia, was correlated to neither abdominal nor general obesity.

Keywords: Central obesity; Dyslipidemia; General obesity; Hypertension; T2DM.

MeSH terms

  • Adult
  • Aged
  • Anthropometry
  • Biomarkers / analysis
  • Body Mass Index
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / metabolism
  • Dyslipidemias / complications
  • Dyslipidemias / epidemiology*
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertension / complications
  • Hypertension / epidemiology*
  • Iran / epidemiology
  • Male
  • Middle Aged
  • Obesity / physiopathology*
  • Prevalence
  • Prognosis
  • Risk Factors
  • Waist Circumference

Substances

  • Biomarkers